REG - BioPharma Credit PLC - Director Declaration

Biopharma CreditAnnouncement

31/10/2023 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231031:nRSe9114Ra&default-theme=true

RNS Number : 9114R  BioPharma Credit PLC  31 October 2023

BioPharma Credit PLC (the "Company")

 

Director Declaration

 

In accordance with Listing Rule 9.6.14 R, the Company has been informed that
Sapna Shah, Non-executive Director of the Company, will be appointed as a
non-executive director of BlackRock Greater Europe Investment Trust plc with
effect from 12 December 2023.

 

 

31 October 2023

 

LEI: 213800AV55PYXAS7SY24

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNMBBATMTTJBPJ